Brief: Amphastar Pharmaceuticals Enters Contract Research Agreement With Hanxin -SEC Filing
18/09/2025 21:55
Sept 18 (Reuters) - SEC Filing: AMPHASTAR PHARMACEUTICALS INC - ON SEPT 15, ENTERS CONTRACT RESEARCH AGREEMENT WITH HANXIN - SEC FILING Source text: [ID:n0001297184-25-000054] Further company coverage: AMPH.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amphastar Pharmaceuticals
See all newsAmphastar Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Amphastar Pharmaceuticals Q2 EPS USD 0.67
U.S. STOCKS ON THE MOVE-RBB Bancorp, Roblox, Open Lending
U.S. STOCKS ON THE MOVE-Amkor Technology, Dynatrace, Corvex
Amphastar rises after FDA approves new over-the-counter overdose spray